Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Razmik Mirzayans

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|November 13, 2025
What Is Apoptosis and Why Is It Inhibited by the Most Important Tumor Suppressor (p53)?Razmik Mirzayans
Current Issues in Molecular Biology|June 26, 2024
Changing the Landscape of Solid Tumor Therapy from Apoptosis-Promoting to Apoptosis-Inhibiting StrategiesRazmik Mirzayans
International Journal of Molecular Sciences|April 13, 2023
The Cellular Response to DNA Damage: From DNA Repair to Polyploidy and BeyondRazmik Mirzayans
International Journal of Molecular Sciences|March 13, 2025
Anastasis and Other Apoptosis-Related Prosurvival Pathways Call for a Paradigm Shift in Oncology: Significance of Deintensification in Treating Solid TumorsRazmik Mirzayans
International Journal of Radiation Biology|January 28, 2020
Nonlinearities in the cellular response to ionizing radiation and the role of p53 thereinDavid Murray, Razmik Mirzayans
International Journal of Molecular Sciences|November 11, 2022
What Are the Reasons for Continuing Failures in Cancer Therapy? Are Misleading/Inappropriate Preclinical Assays to Be Blamed? Might Some Modern Therapies Cause More Harm than Benefit?Razmik Mirzayans, David Murray
International Journal of Molecular Sciences|August 16, 2020
Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer TherapyDavid Murray, Razmik Mirzayans
Cancers|September 14, 2024
Amitotic Cell Division, Malignancy, and Resistance to Anticancer Agents: A Tribute to Drs. Walen and RajaramanRazmik Mirzayans, David Murray
International Journal of Molecular Sciences|February 21, 2020
Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease RecurrenceRazmik Mirzayans, David Murray
International Journal of Molecular Sciences|July 29, 2023
Intratumor Heterogeneity and Treatment Resistance of Solid Tumors with a Focus on Polyploid/Senescent Giant Cancer Cells (PGCCs)Razmik Mirzayans, David Murray
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|November 13, 2025
What Is Apoptosis and Why Is It Inhibited by the Most Important Tumor Suppressor (p53)?Razmik Mirzayans
Current Issues in Molecular Biology|June 26, 2024
Changing the Landscape of Solid Tumor Therapy from Apoptosis-Promoting to Apoptosis-Inhibiting StrategiesRazmik Mirzayans
International Journal of Molecular Sciences|April 13, 2023
The Cellular Response to DNA Damage: From DNA Repair to Polyploidy and BeyondRazmik Mirzayans
International Journal of Molecular Sciences|March 13, 2025
Anastasis and Other Apoptosis-Related Prosurvival Pathways Call for a Paradigm Shift in Oncology: Significance of Deintensification in Treating Solid TumorsRazmik Mirzayans
International Journal of Radiation Biology|January 28, 2020
Nonlinearities in the cellular response to ionizing radiation and the role of p53 thereinDavid Murray, Razmik Mirzayans
International Journal of Molecular Sciences|November 11, 2022
What Are the Reasons for Continuing Failures in Cancer Therapy? Are Misleading/Inappropriate Preclinical Assays to Be Blamed? Might Some Modern Therapies Cause More Harm than Benefit?Razmik Mirzayans, David Murray
International Journal of Molecular Sciences|August 16, 2020
Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer TherapyDavid Murray, Razmik Mirzayans
Cancers|September 14, 2024
Amitotic Cell Division, Malignancy, and Resistance to Anticancer Agents: A Tribute to Drs. Walen and RajaramanRazmik Mirzayans, David Murray
International Journal of Molecular Sciences|February 21, 2020
Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease RecurrenceRazmik Mirzayans, David Murray
International Journal of Molecular Sciences|July 29, 2023
Intratumor Heterogeneity and Treatment Resistance of Solid Tumors with a Focus on Polyploid/Senescent Giant Cancer Cells (PGCCs)Razmik Mirzayans, David Murray
Pageof 4